These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35973004)

  • 21. Production of Cytotoxic Antibodies After Intra-Articular Injection of Allogeneic Synovial Membrane Mesenchymal Stem Cells With and Without LPS Administration.
    Rosa GDS; Krieck AMT; Padula ET; Stievani FC; Rossi MC; Pfeifer JPH; Basso RM; Braz AMM; Golim MA; Alves ALG
    Front Immunol; 2022; 13():871216. PubMed ID: 35572507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.
    Godwin EE; Young NJ; Dudhia J; Beamish IC; Smith RK
    Equine Vet J; 2012 Jan; 44(1):25-32. PubMed ID: 21615465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon.
    Guest DJ; Smith MR; Allen WR
    Equine Vet J; 2010 Oct; 42(7):636-42. PubMed ID: 20840579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
    Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
    Vet Comp Orthop Traumatol; 2013; 26(6):453-60. PubMed ID: 24080668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study.
    Broeckx SY; Martens AM; Bertone AL; Van Brantegem L; Duchateau L; Van Hecke L; Dumoulin M; Oosterlinck M; Chiers K; Hussein H; Pille F; Spaas JH
    Equine Vet J; 2019 Nov; 51(6):787-794. PubMed ID: 30815897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated intra-articular administration of equine allogeneic peripheral blood-derived mesenchymal stem cells does not induce a cellular and humoral immune response in horses.
    Van Hecke L; Magri C; Duchateau L; Beerts C; Geburek F; Suls M; Da Dalt L; Patruno M; Saunders J; Broeckx SY; Depuydt E; Spaas JH
    Vet Immunol Immunopathol; 2021 Sep; 239():110306. PubMed ID: 34365135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of autologous bone marrow and adipose tissue derived mesenchymal stem cells, and platelet rich plasma, for treating surgically induced lesions of the equine superficial digital flexor tendon.
    Romero A; Barrachina L; Ranera B; Remacha AR; Moreno B; de Blas I; Sanz A; Vázquez FJ; Vitoria A; Junquera C; Zaragoza P; Rodellar C
    Vet J; 2017 Jun; 224():76-84. PubMed ID: 28697880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses.
    Pacini S; Spinabella S; Trombi L; Fazzi R; Galimberti S; Dini F; Carlucci F; Petrini M
    Tissue Eng; 2007 Dec; 13(12):2949-55. PubMed ID: 17919069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regenerative medicine laboratory: facilitating stem cell therapy for equine disease.
    Borjesson DL; Peroni JF
    Clin Lab Med; 2011 Mar; 31(1):109-23. PubMed ID: 21295725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of single intralesional treatment of surgically induced equine superficial digital flexor tendon core lesions with adipose-derived mesenchymal stromal cells: a controlled experimental trial.
    Geburek F; Roggel F; van Schie HTM; Beineke A; Estrada R; Weber K; Hellige M; Rohn K; Jagodzinski M; Welke B; Hurschler C; Conrad S; Skutella T; van de Lest C; van Weeren R; Stadler PM
    Stem Cell Res Ther; 2017 Jun; 8(1):129. PubMed ID: 28583184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrin α10β1-Selected Mesenchymal Stem Cells Mitigate the Progression of Osteoarthritis in an Equine Talar Impact Model.
    Delco ML; Goodale M; Talts JF; Pownder SL; Koff MF; Miller AD; Nixon B; Bonassar LJ; Lundgren-Åkerlund E; Fortier LA
    Am J Sports Med; 2020 Mar; 48(3):612-623. PubMed ID: 32004077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Stem Cells for the Treatment of Musculoskeletal Injuries in Horses.
    Watts AE
    Vet Clin North Am Equine Pract; 2023 Dec; 39(3):475-487. PubMed ID: 37625917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome after intra-articular administration of bone marrow derived mesenchymal stem cells in 33 horses with stifle injury.
    Ferris DJ; Frisbie DD; Kisiday JD; McIlwraith CW; Hague BA; Major MD; Schneider RK; Zubrod CJ; Kawcak CE; Goodrich LR
    Vet Surg; 2014 Mar; 43(3):255-65. PubMed ID: 24433318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse.
    Barrachina L; Romero A; Zaragoza P; Rodellar C; Vázquez FJ
    Vet J; 2018 Aug; 238():49-57. PubMed ID: 30103915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn?
    Smith RK; Webbon PM
    Br J Sports Med; 2005 Sep; 39(9):582-4. PubMed ID: 16118291
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of Allogeneic Bone-Marrow-Derived and Umbilical Cord Blood-Derived Mesenchymal Stem Cells to Prevent the Development of Osteoarthritis in An Equine Model.
    Bertoni L; Jacquet-Guibon S; Branly T; Desancé M; Legendre F; Melin M; Rivory P; Hartmann DJ; Schmutz A; Denoix JM; Demoor M; Audigié F; Galéra P
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective analysis of local injection site adverse reactions associated with 230 allogenic administrations of bone marrow-derived mesenchymal stem cells in 164 horses.
    Ursini TL; Amelse LL; Elkhenany HA; Odoi A; Carter-Arnold JL; Adair HS; Dhar MS
    Equine Vet J; 2019 Mar; 51(2):198-205. PubMed ID: 29992618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equine allogeneic chondrogenic induced mesenchymal stem cells: A GCP target animal safety and biodistribution study.
    Broeckx SY; Spaas JH; Chiers K; Duchateau L; Van Hecke L; Van Brantegem L; Dumoulin M; Martens AM; Pille F
    Res Vet Sci; 2018 Apr; 117():246-254. PubMed ID: 29329028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo.
    Pezzanite LM; Fortier LA; Antczak DF; Cassano JM; Brosnahan MM; Miller D; Schnabel LV
    Stem Cell Res Ther; 2015 Apr; 6(1):54. PubMed ID: 25889095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy.
    Smith RK; Werling NJ; Dakin SG; Alam R; Goodship AE; Dudhia J
    PLoS One; 2013; 8(9):e75697. PubMed ID: 24086616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.